¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦1ȸ ¼­¿ï¾Æ»êº´¿ø À¯¹æ¾Ï ½ÉÆ÷Áö¾ö : 2022-08-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦1ȸ ¼­¿ï¾Æ»êº´¿ø À¯¹æ¾Ï ½ÉÆ÷Áö¾ö : 2022-08-27
±³À°ÀÏÀÚ : 2022-08-27
±³À°Àå¼Ò : µ¿°ü ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦1ȸ ¼­¿ï¾Æ»êº´¿ø À¯¹æ¾Ï ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : ÃÖÁ¤Àº
¿¬¶ôó : 02-3010-3499  
À̸ÞÀÏ : chjungeun@amc.seoul.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 09:05~09:20 Personalized anticancer T cell therapy - NeogenTC corp.  ÀÌÈñÁø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 09:20~09:35 Biomedical engineering research and technology development related to surgery for breast cancer patients  °í¹ü¼®(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 09:35~09:50 Circulating tumor DNA for breast cancer and beyond - Genopeaks therapeutics  Á¤Áø±¸(Á¦³ëÇȽº) 
Åä·Ð 08-27 µ¿°ü ´ë°­´ç 09:50~10:00 Discussion  () 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 10:00~10:15 Appropriate Use of 18F-Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Expression of Breast Cancer  ÇÑ»ó¿ø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 10:15~10:30 Neoadjuvant endocrine therapy  ±è¼º¹è(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 10:30~10:45 Hereditary Breast Cancer Update  ±è¼º¿ø(´ë¸²¼º¸ðº´¿ø) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 10:45~11:00 AI in breast imaging  ±èÈñÁ¤(¿ï»êÀÇ´ë) 
Åä·Ð 08-27 µ¿°ü ´ë°­´ç 11:00~11:15 Discussion  () 
È޽Ġ08-27 µ¿°ü ´ë°­´ç 11:15~11:30 Coffee Break  () 
±âŸ 08-27 µ¿°ü ´ë°­´ç 11:30~12:15 ÇູÇÑ À¯¹æ¿Ü°ú 30³â (Á¤³â ±â³ä Special Lecture)  ¾È¼¼Çö(¿ï»êÀÇ´ë) 
½Ä»ç 08-27 µ¿°ü ´ë°­´ç 12:15~13:15 Lunch  () 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 13:15~13:30 Surveys of current practice of adjuvant endocrine therapy  ÀÌ»õº°(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 13:30~13:45 Issues of ovarian function suppression  ³ë¿ìö(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 13:45~14:00 Controversial issues of pregnancy in young breast cancer patients  ÀÌÁ¤¾ð(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 14:00~14:15 Optimal adjuvant systemic therapy based on multigene assay  ÇÑ¿ø½Ä(¼­¿ïÀÇ´ë) 
Åä·Ð 08-27 µ¿°ü ´ë°­´ç 14:15~14:30 Discussion  () 
È޽Ġ08-27 µ¿°ü ´ë°­´ç 14:30~14:45 Coffee Break  () 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 14:45~15:00 Breast cancer patient care plan  Á¤¼Ò¿¬(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 15:00~15:15 Experiences of ARC (AMC referral center)  ±è¼Ò¿¬(Áø·áÇù·ÂÆÀ) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 15:15~15:30 Experiences of breast clinic 1 (¸Ç¶¥¿¡ ÇìµùÇؼ­ °³¾÷Çϱâ)  ¿ì»ó¹Î(ÇÏÀÌÀ¯¿Ü°ú) 
±³À°½Ã°£ 08-27 µ¿°ü ´ë°­´ç 15:30~15:45 Experiences of breast clinic 2  È«¼öÁ¤(¾Æ»êÀ¯¿Ü°ú) 
Åä·Ð 08-27 µ¿°ü ´ë°­´ç 15:45~16:05 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦1ȸ ¼­¿ï¾Æ»êº´¿ø À¯¹æ¾Ï ½ÉÆ÷Áö¾ö : 2022-08-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎÁ¦´ëÇб³ÀÏ»ê¹éº´¿ø ½Å°æ°ú ¿¬¼ö°­Á : 2022-08-27
´ÙÀ½±Û °í´ë±Ùµ¿ÇÐ(¼­¾ç »çÇÐÀڵ鿡 ÀÇÇØ ¹¯ÇôÁø °í´ë±Ùµ¿ÀÇ ¿ª»ç : 2022-08-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20530 ¼­¿ï ¿¡ÀÌÄ¡Ç÷¯½º¾çÁöº´¿ø Á¦2024-1ȸ ¿¬¼ö°­Á : 2024-05-23 0 12 2024-04-29
20529 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ : 2024-05-21 0 5 2024-04-29
20528 ¼­¿ï Á¾·Î±¸ÀÇ»çȸ ȸ¿ø¿¬¼ö±³À°(¾ß°£´¢, ´ç´¢Ä¡·á, ¹ß±âºÎÀü) : 2024-05-21 0 22 2024-04-29
20527 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦2Â÷ ¿¬¼ö±³À° : 2024-05-20 0 6 2024-04-29
20526 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ADHD ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-05-19 0 11 2024-04-29
20525 ¼­¿ï ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ 2024 KSCTVA Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-19 0 12 2024-04-29
20524 ´ë±¸ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 13 2024-04-29
20523 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 15 2024-04-29
20522 ¼­¿ï 2024³â ´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 10 2024-04-29
20521 ¼­¿ï ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-05-18 0 14 2024-04-29
20520 ¿ï»ê ¿ï»ê±¤¿ª½ÃÀÇ»çȸ Ç÷°üÀ» Á¶½ÉÇÏÀÚ : 2024-05-18 0 14 2024-04-29
20519 ¼­¿ï ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ 2024 KSCTVA Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-18 0 6 2024-04-29
20518 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø ¾È°ú ½ÉÆ÷Áö¾ö : 2024-05-18 0 30 2024-04-29
20517 ¼­¿ï ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯ : 2024-05-18 0 16 2024-04-29
20516 ¼­¿ï Á¦7ȸ °­ºÏ±¸ÀÇ»çȸ Çмú´ëȸ : 2024-05-18 0 17 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷